Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 48Lymphoid 46Myeloid 34Plasma cell 33Sarcoma 30Dermatologic 20Classical hematology 16Genitourinary 5Other neoplasm 4CNS 3Head & Neck 2Breast 2Thoracic 1Gynecologic 1

Conditions

Neuroblastoma 12Recurrence 3Osteosarcoma 3Neoplasm Metastasis 3Melanoma 3Brain Neoplasms 3Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Neurofibrosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma 2Leukemia, Myelomonocytic, Juvenile 2Leukemia 2Glioma 2Glioblastoma 2Desmoplastic Small Round Cell Tumor 2Breast Neoplasms 2Wilms Tumor 1Uveal Melanoma 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Paraganglioma 1Neurofibromatosis 1 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1

Interventions

Temozolomide 23Bevacizumab 18Cyclophosphamide 9Carboplatin 7Lomustine 6Irinotecan 63-Iodobenzylguanidine 6Topotecan 5Radiotherapy 5Filgrastim 5Radiosurgery 4Nivolumab 4Everolimus 4Etoposide 4Busulfan 4sonidegib 3pembrolizumab 3olaparib 3fludarabine phosphate 3fludarabine 3antineoplaston AS 2-1 3antineoplaston A10 3Vincristine 3Thiotepa 3Sirolimus 3Melphalan 3IL13-PE38 3Drug Therapy 3Antilymphocyte Serum 3verubulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recurrence × fludarabine phosphate × CNS × Clear all
NCT01822652 2026-04-06

GRAIN

Baylor College of Medicine

Phase 1 Active not recruiting
11 enrolled
CNS

Neuroblastoma, Recurrence

NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Nationwide Children's Hospital

Phase 2 Withdrawn
CNS

Neuroblastoma, Recurrence

NCT00084695 2014-01-10

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
CNSClassical hematologyLymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Recurrence, Sarcoma, Leukemia, Myeloid, Chronic-Phase, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡